Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Myth: GLP-1 patches are FDA approved
Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery dehydration leading to kidney problems
Retatrutide targets all three simultaneously
The scale of Pfizer's planned trial program indicates that obesity is becoming a central theme in its pipeline, alongside cancer and other therapeutic areas
Clinical trial data suggests Retatrutide may produce greater weight loss than semaglutide with trials showing up to 24% total body weight reduction compared to semaglutides approximately 15%
US$ 21.70
US$ 23.49
US$ 27.32
US$ 22.72
